Cargando…
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection
Cytokine storms and extra-activated cytokine signaling pathways can lead to severe tissue damage and patient death. Activation of inflammatory signaling pathways during Cytokine storms are an important factor in the development of acute respiratory syndrome (SARS-CoV-2), which is the major health pr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130726/ https://www.ncbi.nlm.nih.gov/pubmed/35662001 http://dx.doi.org/10.1016/j.acthis.2022.151908 |
_version_ | 1784713033151414272 |
---|---|
author | Rasmi, Yousef. Hatamkhani, Shima. Naderi, Roya. Shokati, Ameneh Nayeb Zadeh, Vajiheh. Hosseinzadeh, Faezeh. Farnamian, Yeganeh. Jalali, Ladan. |
author_facet | Rasmi, Yousef. Hatamkhani, Shima. Naderi, Roya. Shokati, Ameneh Nayeb Zadeh, Vajiheh. Hosseinzadeh, Faezeh. Farnamian, Yeganeh. Jalali, Ladan. |
author_sort | Rasmi, Yousef. |
collection | PubMed |
description | Cytokine storms and extra-activated cytokine signaling pathways can lead to severe tissue damage and patient death. Activation of inflammatory signaling pathways during Cytokine storms are an important factor in the development of acute respiratory syndrome (SARS-CoV-2), which is the major health problem today, causing systemic and local inflammation. Cytokine storms attract many inflammatory cells that attack the lungs and other organs and cause tissue damage. Angiotensin-converting enzyme 2 (ACE2) are expressed in a different type of tissues. inhibition of ACE2 activity impairs renin-angiotensin (RAS) function, which is related to the severity of symptoms and mortality rate in COVID-19 patients. Different signaling cascades are activated, affecting various organs during SARS-CoV-2 infection. Nowadays, there is no specific treatment for COVID-19, but scientists have recognized and proposed several treatment alternatives, including applying cytokine inhibitors, immunomodulators, and plasma therapy. Herein, we have provided the detailed mechanism of SARS-CoV-2 induced cytokine signaling and its connection with pathophysiological features in different organs. Possible treatment options to cope with the severe clinical manifestations of COVID-19 are also discussed. |
format | Online Article Text |
id | pubmed-9130726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91307262022-05-25 Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection Rasmi, Yousef. Hatamkhani, Shima. Naderi, Roya. Shokati, Ameneh Nayeb Zadeh, Vajiheh. Hosseinzadeh, Faezeh. Farnamian, Yeganeh. Jalali, Ladan. Acta Histochem Article Cytokine storms and extra-activated cytokine signaling pathways can lead to severe tissue damage and patient death. Activation of inflammatory signaling pathways during Cytokine storms are an important factor in the development of acute respiratory syndrome (SARS-CoV-2), which is the major health problem today, causing systemic and local inflammation. Cytokine storms attract many inflammatory cells that attack the lungs and other organs and cause tissue damage. Angiotensin-converting enzyme 2 (ACE2) are expressed in a different type of tissues. inhibition of ACE2 activity impairs renin-angiotensin (RAS) function, which is related to the severity of symptoms and mortality rate in COVID-19 patients. Different signaling cascades are activated, affecting various organs during SARS-CoV-2 infection. Nowadays, there is no specific treatment for COVID-19, but scientists have recognized and proposed several treatment alternatives, including applying cytokine inhibitors, immunomodulators, and plasma therapy. Herein, we have provided the detailed mechanism of SARS-CoV-2 induced cytokine signaling and its connection with pathophysiological features in different organs. Possible treatment options to cope with the severe clinical manifestations of COVID-19 are also discussed. Elsevier GmbH. 2022-07 2022-05-25 /pmc/articles/PMC9130726/ /pubmed/35662001 http://dx.doi.org/10.1016/j.acthis.2022.151908 Text en © 2022 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Rasmi, Yousef. Hatamkhani, Shima. Naderi, Roya. Shokati, Ameneh Nayeb Zadeh, Vajiheh. Hosseinzadeh, Faezeh. Farnamian, Yeganeh. Jalali, Ladan. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title | Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title_full | Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title_fullStr | Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title_full_unstemmed | Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title_short | Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection |
title_sort | molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in sars-cov2 infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130726/ https://www.ncbi.nlm.nih.gov/pubmed/35662001 http://dx.doi.org/10.1016/j.acthis.2022.151908 |
work_keys_str_mv | AT rasmiyousef molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT hatamkhanishima molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT naderiroya molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT shokatiameneh molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT nayebzadehvajiheh molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT hosseinzadehfaezeh molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT farnamianyeganeh molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection AT jalaliladan molecularsignalingpathwayspathophysiologicalfeaturesinvariousorgansandtreatmentstrategiesinsarscov2infection |